(S)-1-(3,5-Difluorophenyl)ethanamine
95%
- Product Code: 126386
CAS:
444643-16-7
| Molecular Weight: | 157.16 g./mol | Molecular Formula: | C8H9F2N |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06761827 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
(S)-1-(3,5-Difluorophenyl)ethanamine is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its stereochemistry makes it valuable in the development of enantiomerically pure drugs, particularly those targeting the central nervous system. The compound is often employed in the preparation of inhibitors or modulators for enzymes and receptors, contributing to the treatment of neurological disorders, such as depression or anxiety. Additionally, it serves as an intermediate in the production of compounds with potential therapeutic applications in oncology and infectious diseases. Its unique structure allows for selective interactions with biological targets, enhancing drug efficacy and reducing side effects.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow to Yellow Liquid |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £232.73 |
+
-
|
| 0.250 | 10-20 days | £279.55 |
+
-
|
| 1.000 | 10-20 days | £725.33 |
+
-
|
(S)-1-(3,5-Difluorophenyl)ethanamine
(S)-1-(3,5-Difluorophenyl)ethanamine is primarily utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its stereochemistry makes it valuable in the development of enantiomerically pure drugs, particularly those targeting the central nervous system. The compound is often employed in the preparation of inhibitors or modulators for enzymes and receptors, contributing to the treatment of neurological disorders, such as depression or anxiety. Additionally, it serves as an intermediate in the production of compounds with potential therapeutic applications in oncology and infectious diseases. Its unique structure allows for selective interactions with biological targets, enhancing drug efficacy and reducing side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :